Keywords: 3،4-methylenedioxymethamphetamine; GC-MS; Gas chromatography-mass spectrometry; LC-MS/MS; Liquid chromatography tandem mass spectrometry; TD-ESI-MS; Thermal desorption-electrospray ionization-mass spectrometry; MDMA; 3,4-methylenedioxymethamphetamine; MDA; 3,4-methylenedioxyamphetamine;
مقالات ISI 3،4-methylenedioxymethamphetamine (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 3،4-methylenedioxymethamphetamine; ATS; amphetamine-type stimulants; AM; amphetamine; CE; collision energies; DLLME; dispersive liquid-liquid extraction; GC; gas chromatography; HS-SPME; head-space microextraction; IT/MS; ion trap mass spectrometry; LC; liquid chromatography; LC-UV; liquid
Keywords: 3،4-methylenedioxymethamphetamine; Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: 3،4-methylenedioxymethamphetamine; LC-MS/MS; liquid chromatography-tandem mass spectrometry; MDMA; 3,4-methylenedioxymethamphetamine; MDEA; 3,4-methylenedioxy-N-ethylamphetamine; MDA; 3,4-methylenedioxyamphetamine; sMRM; scheduled multiple reaction monitoring; CLSM; Confocal Laser Scanning
Keywords: 3،4-methylenedioxymethamphetamine; Mephedrone; New psychoactive substances; Monoamine; Receptors; Transporters; 2,3-DMMC; 2,3-dimethylmethcathinone; 2,4-DMMC; 2,4-dimethylmethcathinone; 3,4-DMMC; 3,4-dimethylmethcathinone; 3-MMC; 3-methylmethcathinone; 4-MA; 4-methylamphetamine; 4-MMC; 4-m
Keywords: 3،4-methylenedioxymethamphetamine; ATS; amphetamine-type stimulants; CNS; central nervous system; DFC; drug-facilitated crime; DFSA; drug-facilitated sexual assault; GABA; gamma aminobutyric acid; GHB; gamma hydroxybutyric acid; GBL; gamma butyrolactone; MDA; 3,4-methylenedioxyamphetamine;
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; MDAI; 5,6-methylenedioxy-2-aminoindane; API; active pharmaceutical ingredient; ANFO; ammonium nitrate fuel oil; ANN; artificial neural network; CTAB; cetyltrimethylammonium bromide; CCD; charge-coupled device; CCSW
Keywords: 3،4-methylenedioxymethamphetamine; ADP; adenosine-diphosphate; AK; adenylate kinase; BSO; buthionine sulfoximine; CYP; cytochrome P450; DMEM; Dulbecco's Modified Eagle Medium; DTNB; 5,5â²-dithio-bis(2-nitrobenzoic acid); FCCP; trifluoromethoxy carbonylcyanide phenylhydrazone; FCS; fetal
Keywords: 3،4-methylenedioxymethamphetamine; BMP15; bone morphogenetic protein 15; BPA; bisphenol-A; COC; cumulus cell-oocyte complex; GDF9; growth differentiation factor 9; MDMA; 3,4-methylenedioxymethamphetamine; THC; Î9-tetrahydrocannabinol; Oocyte; Cumulus cells; Gap junctions; Oocyte growth fa
Keywords: 3،4-methylenedioxymethamphetamine; 2-AI; 2-aminoindane; 2C-B; 2,5-dimethoxy-4-bromophenethylamine; 5-IAI; 5-iodo-2-aminoindane; COMT; catechol-O-methyl transferase; CPP; conditioned place preference; DAT; dopamine transporter; DIO; diet-induced obese; DMT; N,N-dimethyltryptamine; EAAT2; ex
Keywords: 3،4-methylenedioxymethamphetamine; Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; NE; norepinephrine; FFA; free fatty acids; CNS; central nervous system; DEA; Drug Enforcement Administration; DA; dopamine; 5HT; serotonin; NET; norepinephrine transporter; DAT; dopamine transporter; SERT; serotoni
Keywords: 3،4-methylenedioxymethamphetamine; 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; ALP; alprazolam; AM; amphetamine; ATC; Anatomical Therapeutic Classification; ATS; amphetamine-type stimulant; BE; benzoylecgonine; BQ; benchmark quotient; BW; body weight; CAF; caffeine; CBD; cannabid
Keywords: 3،4-methylenedioxymethamphetamine; 5-HIAA; 5-hydroxyindoleacetic acid; ASD; autism spectrum disorder; ITGB3; integrin β3 subunit gene; MAOA; mitochondrial bound protein monoamine oxidase A; MAPK; mitogen-activated protein kinase; MDMA; 3,4-methylenedioxymethamphetamine; NAS; N-acetylserot
Keywords: 3،4-methylenedioxymethamphetamine; Wastewater analysis; Surveys; Methamphetamine; 3,4-Methylenedioxymethamphetamine; MDMA; Cocaine;
Keywords: 3،4-methylenedioxymethamphetamine; Complex I; Dopamine; MDMA; Mitochondria; Oxidative stress; AMPT; α-methyl-p-tyrosine; DA; dopamine; MAO; monoamine oxidase; MDMA; 3,4-methylenedioxymethamphetamine; TH; L-tyrosine hydroxylase; ROS; reactive oxygen species;
Keywords: 3،4-methylenedioxymethamphetamine; 3D; three-dimensional; c log P; the calculated log octanol/water partition coefficient; DNA; deoxyribonucleic acid; ATP; adenosine triphosphate; HPT1; intestinal peptide-associated transporter 1; PEPT1; peptide transporter 1; OCT; organic cation transpo
Keywords: 3،4-methylenedioxymethamphetamine; [123I]-β-CIT; 123I-labelled 2b-carbomethoxy-3b-(4-iodophenyl) tropane; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptamine, serotonin; 5-HTT; serotonin transporter; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; ATS; ampheta
Keywords: 3،4-methylenedioxymethamphetamine; 6ACM; 6-acetylmorphine; ALP; alprazolam; AM; amphetamine; ATS; amphetamine-type stimulants; BE; benzoylecgonine; CE; cocaethylene; CO; cocaine; DAs; drugs of abuse; DIA; diazepam; EDDP; 2-ethylene-1,5-dimethyl-3,3-diphenylpyrrolidine; EPs; emerging pollut
Keywords: 3،4-methylenedioxymethamphetamine; CLIA; Clinical Laboratory Improvement Amendments; ED; emergency department; EG; ethylene glycol; HPLC; high pressure (performance) liquid chromatography; POCT; point-of-care testing; TAT; turnaround time; UDT; urine drug testing; MDMA; 3,4-methylenedioxym
Keywords: 3،4-methylenedioxymethamphetamine; a; aerobic stabilization; 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; AF; assessment factor; ALP; alprazolam; AM; amphetamine; ATS; amphetamine-type stimulant; BAS; biologic-activated sludge; BB; bacterial bed; BE; benzoylecgonine; bf; belt-filt
Keywords: 3،4-methylenedioxymethamphetamine; Methylenedioxy designer drugs; 3,4-Methylenedioxymethamphetamine; Glutathione; Glutathione conjugates; High resolution mass spectrometry
Keywords: 3،4-methylenedioxymethamphetamine; 5-HT; serotonin; 5-HTT; serotonin transporter; AMPH; d-amphetamine; ANOVA; analysis of variance; CCD; charge coupled device; COMT; catechol-O-methyltransferase; DA; dopamine; DAT; dopamine transporter; EDTA; ethylenediaminetetraacetic acid; GFAP; glial fi
Life-threatening intoxications related to persistent MDMA (3,4-methylenedioxymethamphetamine) concentrations
Keywords: 3،4-methylenedioxymethamphetamine; 3,4-methylenedioxymethamphetamine; Toxicity; Persistent concentration;
Chronic restraint stress during withdrawal increases vulnerability to drug priming-induced cocaine seeking via a dopamine D1-like receptor-mediated mechanism
Keywords: 3،4-methylenedioxymethamphetamine; CS; conditioned stimuli; D1R; D1-like receptor; FR; fixed ratio; IL; infralimbic; MDMA; 3,4-methylenedioxymethamphetamine; mPFC; medial prefrontal cortex; Abstinence; Cocaine; Dopamine; Reinstatement; Relapse; Stress;
Kinetic mechanism of time-dependent inhibition of CYP2D6 by 3,4-methylenedioxymethamphetamine (MDMA): Functional heterogeneity of the enzyme and the reversibility of its inactivation
Keywords: 3،4-methylenedioxymethamphetamine; Cytochrome P450 2D6; Methylenedioxyphenyl compounds; Time-dependent inhibition; 3,4-methylenedioxymethamphetamine; Mechanism-based inhibition;
3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition
Keywords: 3،4-methylenedioxymethamphetamine; CPA; constant potential amperometry; DA; dopamine; DAT; dopamine transporter; DHβE; dihydroβerythroidine; MDMA; 3,4-methylenedioxymethamphetamine; MLA; methyllycaconitine; nAchR; nicotinic acetylcholine receptor; SNpc; substantia nigra pars compact; 3,4
Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
Keywords: 3،4-methylenedioxymethamphetamine; 2C-B; 2,5-Dimethoxy-4-bromophenethylamine; 4-FA; 4-Fluoroamphetamine; 4-MEC; 4-Methylethcathinone; 4-MMC; 4-Methylmethcathinone, a.k.a. mephedrone; 5-APB; 5-(2-Aminopropyl)benzofuran; 6-APB; 6-(2-Aminopropyl)benzofuran; 5-HT; Serotonin; 25B-NBOMe; 4-Bromo
Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
Keywords: 3،4-methylenedioxymethamphetamine; 3,4-Methylenedioxymethamphetamine; 3,4-Methylenedioxyamphetamine; Pharmacokinetics; CYP1A2; CYP2C19; CYP2B6;
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; Blood-brain barrier; Edema; AQP4; MMP-9; SB-3CT; AQP4; aquaporin 4; GFAP; glial fibrillary acidic protein; LRP-1; lipoprotein receptor-related protein 1; MDMA; 3,4-methylenedioxymethamphetamine; MMP; metalloproteinase; TJ; tight junction; tPA; tissu
Isolated non-cardiogenic pulmonary edema - A rare complication of MDMA toxicity
Keywords: 3،4-methylenedioxymethamphetamine; EMS; Emergency Medical Services; MDMA; 3,4-methylenedioxymethamphetamine; MGM; Mass Gathering Medicine; EDMF; electronic dance music festival; ARDS; Acute Respiratory Distress Syndrome; NCPE; non-cardiogenic pulmonary edema; MDMA; Ecstacy; ARDS; Pulmonary
Development of an on-line microextraction method for use in fiber-spray/mass spectrometry
Keywords: 3،4-methylenedioxymethamphetamine; Fiber-spray/mass spectrometry; Hollow fiber liquid phase microextraction; 3,4-Methylenedioxymethamphetamine;
Motor delays in MDMA (ecstasy) exposed infants persist to 2 years
Keywords: 3،4-methylenedioxymethamphetamine; Behavior; Cocaine; Alcohol; Teratology; 3,4-Methylenedioxymethamphetamine; Infant development; Prenatal; Motor; “Ecstasy”
Acute ascending aortic dissection after MDMA/ecstasy use: A case report
Keywords: 3،4-methylenedioxymethamphetamine; Acute aortic dissection; Ecstasy; 3,4-Methylenedioxymethamphetamine; MDMA; Aortic regurgitation;
Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; LC3; microtubule-associated protein 1 light chain 3; SERT; serotonin transporter; TPH; tryptophan hydroxylase; SSRIs; selective serotonin reuptake inhibitors; 5-HT; 5-hydroxytryptamine (serotonin); 3-MA; 3-methylad
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Keywords: 3،4-methylenedioxymethamphetamine; 5HT1A; 5-hydroxytryptamine (serotonin) receptor 1A; 8-OH-DPAT; 7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol; ADOS-2; Autism Diagnostic Observation Schedule, Second Edition (Module 4); BDI; Beck Depression Inventory; CAPS; Clinician-Administered PTS
Neuroimaging in moderate MDMA use: A systematic review
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; Ecstasy; 3,4-Methylenedioxymethamphetamine; Neuroimaging; MRI; Chronic effects; Adverse effects; Neurotoxicity; Moderate use;
A study to model the post-mortem stability of 4-MMC, MDMA and BZP in putrefying remains
Keywords: 3،4-methylenedioxymethamphetamine; Putrefactive degradation; 4-methylmethcathinone; 3,4-methylenedioxymethamphetamine; N-benzylpiperazine;
Neuropharmacology and analgesiaMDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; PV; parvalbumin; PV-IR; parvalbumin immunoreactive; 5HT; serotonin; GABA; gamma-Aminobutyric acid; NMDA; N-methyl-d-aspartate; AMPA; α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; RT; room temperature; COX-
Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; DMH; dorsomedial hypothalamus; NE; norepinephrine; D1; dopamine 1 receptor; 5-HT-2A; serotonin 2A receptor; MDMA; Hyperthermia; Heat stroke; Locomotion; Dorsomedial hypothalamus;
Does zebra mussel (Dreissena polymorpha) represent the freshwater counterpart of Mytilus in ecotoxicological studies? A critical review
Keywords: 3،4-methylenedioxymethamphetamine; Bivalve; Biological model; Biomarker; Proteomics; Transcriptomics; MTT; 3(4,5-dimethyl-2thiazholyl)-2,5-diphenyl-2H-tetrazolium bromide); MDMA; 3,4-methylenedioxymethamphetamine; AChE; acetylcholinesterase; ABM; active biomonitoring; ALP; alkaline phospha
Interactions between specific parameters of MDMA use and cognitive and psychopathological measures
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-Methylenedioxymethamphetamine; SCL-90; Symptom-Checklist-90; RAVLT; Auditiv-Verbaler Lerntest; LGT; Lern- und Gedächtnistest; HAWIE-R; Hamburg-Wechsler-Intelligenztest; Mini-DIPS; Diagnostisches Kurz-interview bei psychischen Störungen; MANCOV
Short CommunicationTolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats
Keywords: 3،4-methylenedioxymethamphetamine; Cue; MDMA; Reinstatement; Self-administration; Sensitization; Tolerance; CS; conditioned stimulus; FR; fixed ratio; MDMA; 3,4-methylenedioxymethamphetamine; SENS; group of animals that expressed sensitization to the locomotor-activating effects of MDMA; T
Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; HPLC; High Pressure Liquid Chromatography; 5-hydroxytryptamine; 5-HT serotonin; 5-HIAA; 5-hydroxyindoleacetic acid; SERT; serotonin transporter; PND; postnatal date; IP; Intraperitoneal; ANOVA; analysis of variance
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives
Keywords: 3،4-methylenedioxymethamphetamine; Novel psychoactive substance; Monoamine; Transporter; Receptor; 2-AI; 2-aminoindane; BZP; 1-benzylpiperazine; DA; dopamine; DAT; dopamine transporter; D2PM; diphenyl-2-pyrrolidinemethanol; 2-DPMP; desoxypipradrol or 2-diphenylmethylpiperidine; HEK; human
Invited reviewCurrent preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine
Keywords: 3،4-methylenedioxymethamphetamine; Blood-brain barrier disruption; 3,4-Methylenedioxymethamphetamine; Methamphetamine; Neuroinflammation; Basal lamina proteins; IgG extravasation;
Emerging novel roles of neuropeptide Y in the retina: From neuromodulation to neuroprotection
Keywords: 3،4-methylenedioxymethamphetamine; BrdU; 5-bromo-2â²-deoxyuridine; [Ca2+]i; intracellular calcium; CNS; central nervous system; DPP-IV; dipeptidyl peptidase IV; E18; embrionic day 18; ERK; extracellular signal-regulated kinases; GABA; γ-aminobutyric acid; GAD 65; glutamic acid decarboxyl
Looking for prosocial genes: ITRAQ analysis of proteins involved in MDMA-induced sociability in mice
Keywords: 3،4-methylenedioxymethamphetamine; 5-HT1A; serotonin receptor subtype 1a; 5-HT2C; serotonin receptor subtype 2c; FDR; false discovery rate; GHB; gamma-hydroxybutyrate; GPCR; G-protein coupled receptor; iTRAQ; isobaric tag for relative and absolute quantification; LC; liquid chromatography;
3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility
Keywords: 3،4-methylenedioxymethamphetamine; MDMA; 3,4-methylenedioxymethamphetamine; KA; Kainic acid; CaBP; calcium binding proteins; PV; parvalbumin; CB; calbindin; CR; calretinin; Calbindin; Calretinin; Kainic acid; MDMA; Parvalbumin; Seizures;
Developing zebrafish models relevant to PTSD and other trauma- and stressor-related disorders
Keywords: 3،4-methylenedioxymethamphetamine; BDNF; brain-derived neurotrophic factor; COMT; catechol-O-methyltransferase; CRF; corticotropin releasing factor; HTS; high-throughput screens; HPA; hypothalamic-pituitary-adrenal; HPI; hypothalamic-pituitary-interrenal; LSD; lysergic acid diethyl